Investors who applied for the ₹1,450.00 crore initial public offering of Paras Healthcare Limited are set to learn their allocation outcomes today, with share allotment scheduled for finalization on October 26, 2026. The private hospital network is subsequently scheduled to make its dual market listing on both the National Stock Exchange (NSE) and BSE on October 28, 2026, according to Groww's primary market tracking report.
The final subscription numbers reflect selective institutional interest and significant internal employee backing, achieving a cumulative subscription rate of 2.23 times across all eligible categories. Qualified Institutional Buyers (QIBs) led the institutional intake by booking their allocated quota 3.09 times. Retail Individual Investors (RIIs) completed a fully subscribed round at 2.00 times their reserved portion, while the employee quota was oversubscribed by 23.61 times. In contrast, Non-Institutional Investors (NIIs) showed reserved appetite, closing below full capacity at 0.66 times.
How to Check Allocation Status Online
Bidders can review whether they received shares through three authorized digital portals. The primary registrar handling administrative reconciliation is MUFG Intime India Private Limited, which hosts an online lookup tool requiring either an Application Number, Demat DP ID, or Permanent Account Number (PAN).
Additionally, both the BSE Public Issue Portal and the official website of the National Stock Exchange of India provide allotment inquiry services. On these exchange portals, users select the issue name from the drop-down menu, input their application details, and verify their tax identification number to see the total number of shares credited or marked for refund.
Operational Profile and Bed Expansion Road Map
Founded in 1987, Paras Healthcare Limited operates an integrated regional healthcare delivery network under the "Paras Health" brand. As of June 30, 2026, the company operated eight clinical hospital facilities offering an aggregate capacity of 2,211 beds across five states and one union territory in North India, Bihar, and Jharkhand. Its clinical bench included 1,084 doctors and 1,937 nursing professionals.
Proceeds from the fresh capital raise are slated to support major geographical expansion. Paras Healthcare aims to add 300 beds to its Gurugram facility by Fiscal 2027 and develop a 500-bed greenfield center in Ludhiana by Fiscal 2028, positioning its total operational bed count to reach 3,011 by March 2028. Six primary focus areas—cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences—accounted for 74.70% of total operational revenue in Fiscal 2026.
Financial Performance Comparison
The hospital operator's recent financial metrics demonstrate a turnaround from prior bottom-line losses to consecutive profitable periods, supported by operational scale and increased tertiary care volume.
During the three-month period ended June 30, 2026, the hospital chain generated ₹470.28 crore in revenue from operations with a Profit After Tax of ₹49.68 crore, already surpassing the full-year net profit of ₹43.83 crore recorded throughout Fiscal 2026.
| Financial Metric | Q1 FY27 (Ended June 30, 2026) | Full Year FY26 | Full Year FY25 |
|---|---|---|---|
| Revenue from Operations | ₹470.28 crore | ₹1,605.95 crore | ₹1,294.06 crore |
| EBITDA | ₹113.48 crore | ₹335.58 crore | ₹156.46 crore |
| Profit After Tax (PAT) | ₹49.68 crore | ₹43.83 crore | (₹57.98 crore) |
| Operational Bed Capacity | 2,211 beds | 2,211 beds | Baseline expansion |
